Expressive Writing for Depression and Anxiety
(EWMS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a short, three-session writing exercise aimed at helping sexual minority Veterans who face stress from discrimination. It seeks to determine if expressive writing about minority stressors can reduce depression and anxiety linked to these experiences. Participants will either write about their feelings related to these stressors or engage in a neutral writing task about daily activities for comparison. Veterans identifying as gay, lesbian, bisexual, queer, or similar, and who have experienced distress from discrimination, might be a good fit. As an unphased trial, this study offers a unique opportunity to contribute to research that could lead to new support strategies for sexual minority Veterans.
Do I need to stop my current medications to join the trial?
The trial requires that participants be stable on their psychotropic medication for at least 4 weeks, so you do not need to stop taking your current medications if they are stable.
What prior data suggests that this expressive writing intervention is safe for sexual minority Veterans?
Research shows that expressive writing, similar to what the researchers are testing, is generally easy for participants to handle. Studies have found that this type of writing can improve mental health by reducing symptoms of depression and anxiety. For instance, one study discovered that expressive writing led to better moods and less stress over three months.
Expressive writing usually doesn't cause serious side effects. Some people might feel a bit emotional after writing, but this feeling doesn't last long. A therapist often guides the writing process to help manage any discomfort. Overall, expressive writing is considered safe for most people.12345Why are researchers excited about this trial?
Researchers are excited about using expressive writing for depression and anxiety because it offers a unique way to address mental health challenges, especially for sexual minority Veterans. Unlike standard treatments like medication and cognitive-behavioral therapy, this approach focuses on writing about personal experiences related to minority stressors, which can help individuals process emotions and reduce psychological distress. This method is also flexible, as it can be delivered both in-person and via telehealth, making it more accessible. By targeting specific stressors related to minority identity, this approach could offer more tailored support, potentially leading to better mental health outcomes for these individuals.
What evidence suggests that this trial's treatments could be effective for depression and anxiety?
Research has shown that writing about thoughts and feelings can help reduce depression and anxiety. In this trial, participants will engage in Expressive Writing on Minority Stressors, focusing on challenges faced by sexual minority groups. Studies have found that when individuals from these groups write about their specific challenges, their mental health often improves. For instance, writing exercises tailored to different cultures have lessened depression and anxiety. Another study found that this type of writing helps people cope better and manage long-lasting grief. Although these studies do not specifically focus on Veterans, they suggest that writing about personal experiences could also benefit the mental health of sexual minority Veterans. Participants in the control arm will engage in Neutral Writing, focusing on daily activities, to compare the effects.12467
Who Is on the Research Team?
Kelly L Harper, PhD
Principal Investigator
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Are You a Good Fit for This Trial?
This trial is for sexual minority Veterans experiencing significant depression or anxiety, who have faced discrimination due to their sexuality. They must score above 10 on specific mental health scales and identify as non-heterosexual. Those with severe substance use disorders, cognitive impairments, suicidal plans/intent, or unstable mania/psychosis cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 3-session expressive writing intervention targeting distress related to sexual minority stressors
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Expressive Writing on Minority Stressors
- Neutral Writing
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor